Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants. - Wikidata - awgldk - TriplyDB

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

http://www.wikidata.org/entity/Q37034798

about

HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu Province, China A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.

P2860

Q33685740-52CC168A-440E-4BAF-8897-369D101ADD99 Q37517645-479A8C46-20C1-4D20-B57F-FC903518AF0F

P2860

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

http://www.wikidata.org/entity/Q37034798

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

@en

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

@nl

type

label

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

@en

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

@nl

prefLabel

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

@en

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

@nl

P1433

Q37034798-69C53F63-6696-47A5-9F6D-8992C86975AE

P1476

Q37034798-41396969-8A3D-4914-A8EC-5B311A1C19F7

P2093

Q37034798-26981B7E-A772-433C-B80C-A5AB93C453F5

Q37034798-286C1E22-C984-4311-A982-B10A82610B55

Q37034798-3CC0031E-6F62-479D-A60E-08BE37017471

Q37034798-4711C5BD-22D6-4B0C-92D6-9CB917285B6E

Q37034798-960E9D3F-B807-4899-9E82-BB4F262FE6B8

Q37034798-A5E5E6D0-E953-4772-9D25-85CE06951E74

Q37034798-C4937038-1146-4960-BFC2-310F4D587436

Q37034798-C6546948-508E-4DC2-A01A-BCF477B2ADF0

Q37034798-CCC14959-539F-4653-8114-329FE9A203C2

Q37034798-EDCADD9C-829B-4522-850A-042C017DB5BC

P2860

Q37034798-08C8D84E-8860-44B1-8F51-A5E371D61DEC

Q37034798-0BCDF465-94B6-468D-A99D-3E49ACBB41A1

Q37034798-17C90390-4AE1-4836-B053-C2DE28FF3CBC

Q37034798-19F242AB-A4EA-4D73-A4EF-B10F3773A6E1

Q37034798-1A4791E1-9D61-43B8-83C8-CC65547FDB00

Q37034798-22507854-38D9-4BC8-832A-A1C37E1ACA08

Q37034798-22602C8B-93E8-492B-A712-74FE3204F470

Q37034798-251F0729-22F5-486A-B791-70373882C630

Q37034798-27930EFE-F762-4E73-880E-51D0BC0D3595

Q37034798-2A62CBEB-23D5-4824-82C4-7AC3F2BD396A

P304

Q37034798-03EC72E9-2B94-42AE-837B-AA2F9C007FB2

P31

Q37034798-A6D51C8E-35D1-4388-A35D-A77C27E04456

P356

Q37034798-46206A4C-8D1E-47AF-8ECE-F4D670314101

P478

Q37034798-0862A4E6-EB50-4267-967A-2E30FE857563

P50

Q37034798-47DC274D-45E3-4C31-BE20-0EDD50891356

P577

Q37034798-FD260446-B4BB-412C-AA3E-E79763A79E83

P698

Q37034798-4B701826-ADA5-4853-BD72-213C667F8AA4

P932

Q37034798-6EEBA820-92EC-4213-AEB4-EE1A5A9DC35A

P356

J.EBIOM.2016.04.040

P1433

P1476

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.

@en

P2093

Behzad Etemad

http://www.w3.org/2001/XMLSchema#string

Carlos Becerril

http://www.w3.org/2001/XMLSchema#string

Daniel R Kuritzkes

http://www.w3.org/2001/XMLSchema#string

Hong Lu

http://www.w3.org/2001/XMLSchema#string

Ludy Registre

http://www.w3.org/2001/XMLSchema#string

Manish Sagar

http://www.w3.org/2001/XMLSchema#string

Myron Essex

http://www.w3.org/2001/XMLSchema#string

Nina Lin

http://www.w3.org/2001/XMLSchema#string

Oscar A Gonzalez

http://www.w3.org/2001/XMLSchema#string

Sikhulile Moyo

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

Antibody neutralization and escape by HIV-1

Broad neutralization coverage of HIV by multiple highly potent antibodies

P304

237-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2016.04.040

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27428434

http://www.w3.org/2001/XMLSchema#string

P932

4919596

http://www.w3.org/2001/XMLSchema#string